Literature DB >> 18772611

Novel mutations in 21 patients with tuberous sclerosis complex and variation of tandem splice-acceptor sites in TSC1 exon 14.

Teguh Haryo Sasongko1, Mari Wataya-Kaneda, Keiko Koterazawa, Surini Yusoff, Indra Sari Kusuma Harahap, Myeong Jin Lee, Masafumi Matsuo, Hisahide Nishio.   

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by epilepsy, mental retardation, skin lesions, and tumors in various organs. However, TSC is sometimes difficult to diagnose because of its broad phenotypic spectrum. In such cases, it is essential to find a mutation in the disease-causing genes, TSC1 and TSC2. In this study, we analyzed 21 TSC patients from 16 families using a combination method of DHPLC and nucleotide sequencing. We identified 16 novel mutations in the 16 families: nine mutations in TSC1 (1 insertion, 7 deletion and 1 nonsense mutations) and seven mutations in TSC2 (2 insertion, 2 deletion, 1 missense mutations and 2 splicing abnormalities). We also tested the possibility of very short alternative splicing due to a variation of the tandem splice-acceptor sites of TSC1 exon 14 in a patient. RT-PCR and sequencing analysis indicated that no alternative splicing occurred in the patient. In conclusion, we confirmed the diagnosis of all patients using mutation analysis and clarified that variation of the tandem splice-acceptor sites in TSC1 exon 14 does not cause a splicing abnormality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772611

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  5 in total

1.  MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research.

Authors:  Wendy Chang; Andrew S Brohl; Rajesh Patidar; Sivasish Sindiri; Jack F Shern; Jun S Wei; Young K Song; Marielle E Yohe; Berkley Gryder; Shile Zhang; Kathleen A Calzone; Nityashree Shivaprasad; Xinyu Wen; Thomas C Badgett; Markku Miettinen; Kip R Hartman; James C League-Pascual; Toby N Trahair; Brigitte C Widemann; Melinda S Merchant; Rosandra N Kaplan; Jimmy C Lin; Javed Khan
Journal:  Clin Cancer Res       Date:  2016-03-18       Impact factor: 12.531

2.  Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis.

Authors:  Evgeny N Suspitsin; Grigoriy A Yanus; Marina Yu Dorofeeva; Tatiana A Ledashcheva; Nataliya V Nikitina; Galina V Buyanova; Elena V Saifullina; Anna P Sokolenko; Evgeny N Imyanitov
Journal:  J Hum Genet       Date:  2018-02-23       Impact factor: 3.172

3.  TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review.

Authors:  Clévia Rosset; Cristina Brinckmann Oliveira Netto; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2017-02-20       Impact factor: 1.771

4.  Comprehensive Genetic Analysis Results of TSC1/TSC2 Genes in Patients with Clinical Suspicion of Tuberous Sclerosis Complex and Definition of 3 Novel Variants.

Authors:  Selma Demir; Sinem Yalçıntepe; Engin Atlı; Yelda Yalçın; Emine İkbal Atlı; Damla Eker; Yasemin Karal; Hakan Gürkan
Journal:  Balkan Med J       Date:  2021-11       Impact factor: 2.021

5.  Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients.

Authors:  Mari Wataya-Kaneda; Mari Tanaka; Toshimitsu Hamasaki; Ichiro Katayama
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.